Oral HPV-Related Epithelial Proliferation during Fingolimod Therapy: First Case Report and Review of the Literature
{{output}}
Fingolimod, an immunomodulatory agent used in the treatment of multiple sclerosis, has been associated with an increased risk of human papillomavirus (HPV)-related mucocutaneous lesions due to its immunosuppressive effects. We report the first documented case ... ...
